1 |
Collins, G. N., & Simpson, R. J. (1993). Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men. Br J Gen Pract, 43, 318-321
PUBMED
|
2 |
Girman, C. J., Panser, L. A., Epstein, R. S., Oesterling, J. E., Jacobsen, S. J., Lieber, M. M., & Guess, H. A. (1994). Natural history of prostatism: Impact of urinary symptoms on quality of life in 2115 randomized selected community men. Urol, 44(6), 825-831
DOI
ScienceOn
|
3 |
Homma, Y., Kawabe, K., Tsukamoto, T., Yamanaka, H., Okada, K., Okajima, E., Yoshida, O., Kumazawa, J., Fang-Liu, G., Lee, C, Hsu, T-C, Cruz, R. C. D., Tantiwang, A., Lim, P., Sheikh, M. A., Bapat, S. D., Marshall, V. R., Tajima, K., & Aso, Y. (1997). Epidemiologic survey of lower urinary tract symptoms in Asia and Australia Using international prostatic symptom score. Int J Urol, 4(1), 40-46
DOI
ScienceOn
|
4 |
Hunt, S. M., McKenna, S. P., McEwen, J., Williams, J., & Papp, E. (1981). The Nottingham health profile: Subjective health status and medical consultations. Soc Sci Med, 15, 221-219
|
5 |
McConnell, J. D., Barry, M. J., Bruskewitz, R. C, Bueschen, A. J., Denton, S. E., & Holtgrewe, H. L. (1994). Benign prostatic hyperplasia: Diagnosis and treatment. Clinical practice guideline, Number 8. Rockville, MD, US Department of Health and Human Services. Public Health Service, Agency for Health Care Policy and Research
|
6 |
Nacey, J. N., Morum, P., & Delahunt, B. (1995). Analysis of the prevalence of voiding symptoms in Maori, pacific island and Caucasian New Zealand men. Urol, 46(4), 506-511
DOI
ScienceOn
|
7 |
Naughton, M. J., & Wyman, J. F. (1997). Quality of life in geriatric patients with lower urinary tract dysfunction. Am J Med Sci, 314, 219-227
DOI
ScienceOn
|
8 |
Park, J-H., & Kwon, Y-C. (1989). Standardization of Korean version of the mini-mental state examination for use in elderly: Part II. Diagnostic validity. J Korean Neuropsychia Asso, 28(3), 508-513
|
9 |
WHOQOL group. (1998). Development of the World Health Organization WHOQOL-BRIF Quality of life assessment. Psycho Med, 28, 551-558
DOI
PUBMED
ScienceOn
|
10 |
Norman, R. W., Nickel, J. C, Fish, D., & Pickett, S. N. (1994). Prostate-related symptoms in Canadian men 50 years of age or older: prevalence and relationships among symptoms. J Urol, 74, 542-550
DOI
ScienceOn
|
11 |
Terai, A., Kakehi, Y., Terachi, T., & Ogawa, O. (2000). National trend of management of benign prostatic hyperplasia in Japan during 1990s: Analysis of national health statistics. Hinyokika Kiyo, 46(8), 537-544
|
12 |
Barry, M. J., Fowler, F. J., Jr O'Leary, M. P., Bruskewitz, R. C, Holtgrewe, H. L., Mebust, W. K., & Cockett, A. T. K. (1992). The American Urological Association symptom index for benign prostatic hyperplasia: The measurement committee of the American Urological Association. J Urol, 148,1549-1557
DOI
PUBMED
|
13 |
Garraway, W. M., Mckelvie, G. B., Russell, E. B. A. W., Hehir, M., Lee, R. J., Rogers, C. A. N., Tsang , K. K., & Garraway, W. M. (1993) Impact of benign prostatic hyperplasia on general well being of men. Prostate, 23,1-7
DOI
ScienceOn
|
14 |
Ware, J. E., & Sherbourne, C. D. (1993). A 36-item Short-Form health survey (SF-36): Conceptual framework and item selection. Med Care, 30, 478-483
|
15 |
Fayers, P. M., & Machin, D. (2000). Quality of life: Assessment, analysis and interpretation. Wiley: West Sussex, England
|
16 |
Lee, E. S., Lee, C, Kim, Y. S., & Sin, Y. (1995). Estimation of benign prostatic hyperplasia prevalence in Korea: An epidemiology survey using International Prostatic Symptom Score in Yonchon country. Korean J Urol, 36(12), 1345-1352
|
17 |
Kortt, M. A., & Bootman, J. L. (1996). The economics of benign prostatic hyperplasia treatment: A literature review. Clin Ther, 18(6), 1227-1241
DOI
ScienceOn
|
18 |
Saniger, P. P., MacFarlane, G., & Teillac, P. (1995). Impact of symptoms of prostatism on level of bother and quality of life of men in the France community. J Uro, 153, 669-673
DOI
PUBMED
ScienceOn
|
19 |
Garraway, W. M., Collins, G. N., & Lee, R. J. (1991). High prevalence of benign prostate hypertrophy in the community. Lance, 338, 469-471
DOI
ScienceOn
|
20 |
Korea National Statistical Office. Population. (2001). Korea National Statistical Office, Seoul
|
21 |
Trueman, P., Hood, S. C, Nayak, U. S. L., & Mrazek, M. F. (1999). Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK. BJU Inter, 83, 410-415
DOI
ScienceOn
|
22 |
Choi, H. R., Chung, W. S., Shim, B. S., Kwon, S. W., Hong, S. J., Chung, B. H., Sung, D. H., Lee, M. S., & Song, J. M. (1996). Translation validation and reliability of I-PSS Korean version. Korean J Urol, 37, 659-665
|
23 |
Tsukamoto, T., Kumamoto, T., Masumori, N., Miyake, H., Rhodes, T., Girman, C. J, Guess, H. A., Jacobsen, S. J., & Lieber, M. M. (1995). Prevalence of prostatism in Japanese men in a community-based study with comparison to a similar American study. J Urol, 154, 391-395
DOI
PUBMED
ScienceOn
|
24 |
Drummond, M. F., McGuire, A. J., Black, N. A., Petticrew, M., & McPherson, C. K. (1993). Economic burden of treating benign prostatic hyperplasia in the United Kingdom. Br J Urol, 71, 290-296
DOI
ScienceOn
|
25 |
Korean Medical Insurance Corporation. (1995). '94 Medical Insurance Statistical Yearbook. Korean Medical Insurance Corporation, Seoul
|
26 |
Hunter, D. J. W., & Berra-Unamuno, A. (1997). Treatment-seeking behavior and stated preferences for prostatectomy in Spanish men with lower urinary tract symptoms. Br J Urol, 79, 742-748
DOI
PUBMED
|
27 |
Bosch, J. H. R., Hop, W. C. J., Kirkel, W. J., & Schroder, F. H. (1995) The international prostate symptom score in a community-based sample of men between 55 and 74 years of age: Prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. J Urol, 75, 622-630
DOI
ScienceOn
|